EUVIMEDOdkrijte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications

Gabriele Simonetti iD, Francesco Catamerò iD, Giulia Liccioli iD, Leonardo Tomei iD, Simona Barni iD, Mattia Giovannini iD, Lucrezia Sarti iD, Francesca Mori iD

Contact Dermatitis · 2026

DOI: 10.1111/cod.70203 ↗

At a glance

Übersichtsarbeit in Contact Dermatitis, 2026. Written by Gabriele Simonetti and 7 co-authors. Institution: Department of Health Sciences, University of Florence, Florence, Italy. Major MEDLINE topics: Patch Tests, Drug Hypersensitivity, Drug Eruptions. 49 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis. However, its role in paediatric DHRs remains unclear. Available data indicate that PT is safe and particularly useful when drug provocation testing is contraindicated, such as in patients with severe cutaneous adverse reactions. However, diagnostic yield varies considerably among drug classes and clinical phenotypes. Sensitivity is generally low for beta‐lactam and most non–beta‐lactam antibiotics, which limits their standalone value in common exanthematous reactions. Higher positivity rates have been reported for antiepileptic drugs, and PT may help identify the culprit drug and assess its cross‐reactivity. However, evidence supporting the use of nonsteroidal anti‐inflammatory drugs and paracetamol remains scarce. Methodological heterogeneity and limited paediatric‐specific data further constrain this interpretation. Overall, PT should be considered as a complementary diagnostic tool integrated with clinical history and other tests, highlighting the need for standardized protocols and prospective paediatric studies.

Subjects

MeSH terms (MEDLINE)

Patch TestsDrug HypersensitivityDrug EruptionsHumansChildAnticonvulsantsAnti-Inflammatory Agents, Non-Steroidal

Author keywords

SCARschildrendiagnosisdrug allergypatch test

Substances

AnticonvulsantsAnti-Inflammatory Agents, Non-Steroidal

Authors and institutions

  • Department of Health Sciences, University of Florence, Florence, Italy.
  • Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.

ORCID profiles: Gabriele Simonetti, Francesco Catamerò, Giulia Liccioli, Leonardo Tomei, Simona Barni, Mattia Giovannini, Lucrezia Sarti, Francesca Mori

Cite

APA

Simonetti, G., Catamerò, F., Liccioli, G., Tomei, L., Barni, S., Giovannini, M., Sarti, L., & Mori, F. (2026). Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications. Contact Dermatitis. https://doi.org/10.1111/cod.70203

Vancouver

Simonetti G, Catamerò F, Liccioli G, Tomei L, Barni S, Giovannini M, et al. Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications. Contact Dermatitis. 2026. doi:10.1111/cod.70203

BibTeX
@article{Simonetti2026,
  author = {Simonetti, Gabriele and Catamerò, Francesco and Liccioli, Giulia and Tomei, Leonardo and Barni, Simona and Giovannini, Mattia and Sarti, Lucrezia and Mori, Francesca},
  title = {Patch Testing in Paediatric Drug Hypersensitivity Reactions: Current Evidence and Clinical Implications},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70203}
}
Start for free →